Company
Novelty Nobility
Leadership
SAB
Contact Us
Platform
PREXISE-D
Pipeline
People
Culture
Careers
News
Careers
Publications
Blog
OTD Solution
Terms of Use
Private Policy
ddd
Company
Novelty Nobility
Leadership
SAB
Contact Us
Platform
PREXISE-D
Pipeline
People
Culture
Careers
News
Careers
Publications
Blog
OTD Solution
Terms of Use
Private Policy
PREXISE-D, Fit-for-Purpose
Antibody Design & Discovery
Learn more
Overcoming Drug Resistance
with Antibody-Drug Conjugate
Learn more
Bringing a Beautiful Moment of
Eye Contact to Everyone
Learn more
NEWS
[더벨] 노벨티노빌리티 "계획된 기술반환…핵심역량은 ADC"
[이데일리] 예심청구 노벨티노빌리티, 기술반환..."신규 L/O 재추진 노력"...
[메디코파마] 노벨티노빌리티, ADC 항암제 美임상 본격화
[조선비즈] 노벨티노빌리티, 코스닥 상장예심 청구…“상반기 상장 목표”
[히트뉴스] 노벨티노빌리티, 233억 시리즈C 투자 유치… 내년 코스닥 상장 목표...